Literature DB >> 31482755

Can we predict surgical margin positivity while performing cervical excisional procedures?

Yasin Durmuş1, Alper Karalök1, Derman Başaran1, Mustafa Onur Kamani1, Nurettin Boran1, Sevgi Koç1, Ahmet Taner Turan1.   

Abstract

We designed this study to evaluate any factors associated with positive surgical margin in conisation specimens and to determine the optimal cone size. The medical records of patients who had undergone a loop electrosurgical excision procedure (LEEP), cold-knife conisation (CKC) and needle excision of the transformation zone (NETZ) procedure were reviewed retrospectively. Two hundred and sixty eight women fulfilled the inclusion criteria. Univariate analyses showed that 'postmenopause', 'HSIL on smear', 'previous colposcopic examination revealing HSIL in endocervical curettage (ECC) material and in two or more ectocervical quadrants' and 'managing with LEEP' were significant predictors of surgical margin positivity. Nulliparous patients showed significantly lower rate of surgical margin positivity. 'Postmenopause', 'previous colposcopic examination revealing HSIL in ECC material and in two or more ectocervical quadrants' and 'HSIL on smear' were identified as independent predictors of surgical margin positivity according to multivariate analyses.IMPACT STATEMENTWhat is already known on this subject? Previous studies demonstrated 'menopause', 'Age ≥50', 'managing with LEEP', 'disease involving >2/3 of cervix at visual inspection', 'training level of the surgeon', 'cytology squamous cell carcinoma' and 'mean cone height' as factors associated with positive surgical margin in conisation specimens.What do the results of this study add? In our study, univariate analyses showed that 'postmenopause', 'HSIL on smear', 'previous colposcopic examination revealing HSIL in endocervical curettage material and in two or more ectocervical quadrants' and 'managing with LEEP' were associated with surgical margin positivity. On the other hand, nulliparous women showed significantly lower rate of surgical margin positivity compared with parous women. Multivariate analyses showed that 'postmenopause', 'previous colposcopic examination revealing HSIL in endocervical curettage material and in two or more ectocervical quadrants' and 'HSIL on smear' were independent predictors of surgical margin positivity in conisation specimens.What are the implications of these findings for clinical practice and/or further research? We can predict high-risk patients with regard to surgical margin positivity. Prediction of high-risk patients and management with a tailored approach may help minimise surgical margin positivity rates.

Entities:  

Keywords:  CIN; Conisation; HSIL; LEEP; LSIL; surgical margin

Year:  2019        PMID: 31482755     DOI: 10.1080/01443615.2019.1645101

Source DB:  PubMed          Journal:  J Obstet Gynaecol        ISSN: 0144-3615            Impact factor:   1.246


  4 in total

1.  The role of endocervical curettage in detection and treatment of cervical canal lesions.

Authors:  Lin Lang; Ying Jia; Zhaoning Duan; Jin Wu; Ming Luo; Pu Tian
Journal:  Histol Histopathol       Date:  2021-11-09       Impact factor: 2.303

2.  Evaluation of Factors Affecting Margin Positivity and Persistent Disease After Leep for Cervical Intraepithelial Neoplasia.

Authors:  Anila Tresa Alukal; P Rema; S Suchetha; Dhanya Dinesh; Aleyamma Mathew; K M Jagathnath Krishna; Thara Somanathan; J Sivaranjith
Journal:  J Obstet Gynaecol India       Date:  2021-03-12

3.  Clinical Outcomes Associated with Endocervical Glandular Involvement in Patients with Cervical Intraepithelial Neoplasia III.

Authors:  Nae Ry Kim; Zee Hae Baek; A Jin Lee; Eun Jung Yang; Yung-Taek Ouh; Mi Kyung Kim; Seung-Hyuk Shim; Sun Joo Lee; Tae Jin Kim; Kyeong A So
Journal:  J Clin Med       Date:  2022-05-25       Impact factor: 4.964

4.  Construction and Evaluation of a Clinical Prediction Scoring System for Positive Cervical Margins Under Colposcopy.

Authors:  Meiling Zhu; Mingyue Yu; Zhengzheng Chen; Weidong Zhao
Journal:  Front Med (Lausanne)       Date:  2022-02-28
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.